Business

ENDRA Life Sciences to Host Second Quarter 2020 Financial Results Conference Call and Webcast on Monday, August 17, 2020 at 4:30 p.m. ET

ANN ARBOR, MI / ACCESSWIRE / August 5, 2020 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS™),

articleEndra Life Sciences Inc.August 5, 20205/company/endra-life-sciences-inc/news/endra-life-sciences-to-host-second-quarter-2020-financial-results-conference-call-and-webcast-on-monday-august-17-2020-at-430-pm-et
ENDRA Life Sciences to Host Second Quarter 2020 Financial Results Conference Call and Webcast on Monday, August 17, 2020 at 4:30 p.m. ET

About this update from Endra Life Sciences Inc.

[{"type":"text","content":"ANN ARBOR, MI / ACCESSWIRE / August 5, 2020 / ENDRA Life Sciences Inc. (\"ENDRA\") (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS™), today announced that its second quarter financial results will be released on Friday, August 14, 2020 after the U.S. financial markets close. Management will host a conference call and webcast on Monday, August 17, 2020 at 4:30 p.m. ET to discuss the results and provide an update on recent corporate developments.Dial-in NumberU.S./Canada Dial-in Number: 844-369-8774International Dial-in Number: 862-298-0844Replay Dial-in Number: 877-481-4010Replay International Dial-in Number: 919-882-2331Replay Passcode: 36535A telephone replay will be available August 17, 2020 through 4:30 p.m. ET on August 24, 2020.A live audio webcast will be available through the Events and Presentations page of the Investors section of the company's website at www.endrainc.com. A replay of the webcast will be available on the website for 90 days.About ENDRA Life Sciences Inc.ENDRA Life Sciences is the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS™), a ground-breaking technology being developed to visualize tissue like CT or MRI, but at 1/50th of the cost, at the point of patient care. TAEUS is designed to work in concert with the over one million ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver, as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and inflammation (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, ENDRA is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures. www.endrainc.com.Company Contact:David WellsChief Financial Officer(734) [email protected] Relations Contact:Denise DiMeglio(610) [email protected] Relations Contact:Joe [email protected]: ENDRA Life Sciences Inc.View source version on accesswire.com: https://www.accesswire.com/600328/ENDRA-Life-Sciences-to-Host-Second-Quarter-2020-Financial-Results-Conference-Call-and-Webcast-on-Monday-August-17-2020-at-430-pm-ET","length":3986,"tagName":"div"}]

More updates from Endra Life Sciences Inc.